21-OH gene therapy for CAH - BBP-631 BBIO – CAH GTx BBP-631 – ASGCT 2021 – NHP BBIO – CAH GTx BBP-631 – ENDO 2021 – Phase 1/2 Study Design BBIO – CAH GTx BBP-631 – ESGCT 2019 – NHP
